Long-term Antibiotics and Simple TEVAR for Treatment of Infectious Thoracic Aortic Aneurysm
Hiroshima Journal of Medical Sciences 66 巻 4 号
103-108 頁
2017-12 発行
アクセス数 : 1163 件
ダウンロード数 : 171 件
今月のアクセス数 : 8 件
今月のダウンロード数 : 1 件
この文献の参照には次のURLをご利用ください : https://ir.lib.hiroshima-u.ac.jp/00045402
ファイル情報(添付) |
HiroshimaJMedSci_66_103.pdf
393 KB
種類 :
全文
|
タイトル ( eng ) |
Long-term Antibiotics and Simple TEVAR for Treatment of Infectious Thoracic Aortic Aneurysm
|
作成者 |
Katayama keijiro
Watanabe Masazumi
Go Seimei
Morita Shohei
|
収録物名 |
Hiroshima Journal of Medical Sciences
|
巻 | 66 |
号 | 4 |
開始ページ | 103 |
終了ページ | 108 |
収録物識別子 |
[PISSN] 0018-2052
[EISSN] 2433-7668
[NCID] AA00664312
|
抄録 |
Purpose: The principle treatment of infectious aortic aneurysm is to remove the infected aneurysm and replace it with Rifampicin-soaked prosthesis by omentopecxy. This study aimed to clarify the efficacy of long-term antibiotics and subsequent thoracic endovascular aneurysm repair (TEVAR) for infectious thoracic aortic aneurysm.
Methods: Between July 2011 and December 2015, 213 TEVARs were performed at Hiroshima University Hospital. Six patients (2.8%) had infectious aneurysm and received long-term antibiotic therapy and secondary TEVAR. L ong-term antibiotic therapy and subsequent TEVAR is paradoxical. This study aimed to clarify the timing of TEVAR for infectious thoracic aortic aneurysm. Results: All patients presented with fever and back pain, and had positive blood cultures; five patients had significant co-morbidities. Bacteraemia was caused by Methicillin Sensitive Staphylococcus Aureus (MSSA) (2), Streptococcus sanguinis (1), Methicillin Resistant Staphylococcus Aureus (MRSA) (1), Chryseobacterium meningosepticum (1), and Enterococcus faecalis (1). B lood examination at admission revealed a WBC count ranging from 10,470 to 16,170/μl and CRP ranging from 7.9 to 16.4 mg/dl. Long-term antibiotic therapy was continued until WBC and CRP were within the normal range. TEVAR was performed emergently in 3 cases and electively in 3 cases. The time from admission to TEVAR ranged from 7 to 26 days. One stent-graft was deployed in all 6 cases. All patients survived and were followed for an average of 48 months; they were free from re-infection. Conclusion: Long-term antibiotics and simple TEVAR may be a feasible treatment for infectious thoracic aortic aneurysms. |
著者キーワード |
thoracic aortic aneurysm
bacteremia
TEVAR
|
NDC分類 |
医学 [ 490 ]
|
言語 |
英語
|
資源タイプ | 紀要論文 |
出版者 |
Hiroshima University Medical Press
|
発行日 | 2017-12 |
権利情報 |
Copyright (c) 2017 Hiroshima University Medical Press
|
出版タイプ | Version of Record(出版社版。早期公開を含む) |
アクセス権 | オープンアクセス |
収録物識別子 |
[ISSN] 0018-2052
[ISSN] 2433-7668
[NCID] AA00664312
[DOI] 10.24811/hjms.66.4_103
[DOI] https://doi.org/10.24811/hjms.66.4_103
|